teaser
Pharmaceutical company Akorn has received FDA approval for its generic version of the painkiller Dilaudid-HP.
The drug maker will begin shipping the treatment next month.
Akorn also said it had commenced work on an injectable version of vancomycin HCL, an antibiotic used to fight life-threatening infections.
↓Article continues below this sponsored advert↓
Explore the latest advances in cardiovascular care delivered by renowned experts from recognised Centres of Excellence and other NHS trusts around the UK. Gain CPD, put your burning questions to the experts, and boost your confidence when it comes to care for your patients.
↑Advertisement↑
Raj Raj, the firm’s interim chief executive officer, said: “These opportunities represent important milestones for our company and are integral to the execution of our strategy to deliver high value pharmaceuticals.”
Akorn specialises in hospital and ophthalmic pharmaceuticals. It also produces injectables, TB drugs, antidotes, analgesics and anaesthetics and rheumatoid arthritis treatments.
Copyright Press Association 2010
